Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids Cover

.blurhash-client-img { display: none !important; }

Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids

Acta Pharmaceutica

Volume 74 (2024): Issue 4 (December 2024)

By: Goran Poje , Davor Šakić , Marina Marinović , Jiangyang You , Michael Tarpley , Kevin P. Williams , Nikolina Golub , Jaka Dernovšek , Tihomir Tomašič , Erim Bešić and Zrinka Rajić

Open Access

|Jan 2025

DOI: https://doi.org/10.2478/acph-2024-0033 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 595 - 612

Accepted on: Aug 19, 2024

|

Published on: Jan 9, 2025

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

hybrid compounds,

antiproliferative activity,

glioblastoma multiforme,

antioxidant activity,

EPR spectroscopy

Related subjects:

Pharmacy, other

© 2025 Goran Poje, Davor Šakić, Marina Marinović, Jiangyang You, Michael Tarpley, Kevin P. Williams, Nikolina Golub, Jaka Dernovšek, Tihomir Tomašič, Erim Bešić, Zrinka Rajić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 74 (2024): Issue 4 (December 2024)Next article